BIO-TECHNE Corp
For the period ended Jun 30, 2024. Filed Aug 22, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Aug 22, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
| | ||||
| BIO-TECHNE CORPORATION | ||||
| | ||||
| Date: August 22, 2024 | | /s/ Kim Kelderman | ||
|---|---|---|---|---|
| | By: | Kim Kelderman | ||
| | | | Its: | President and CEO |
Pursuant to the requirements of the Securities Exchange Act of 1934, this Report has been signed by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| | ||
| Date | | Signature and Title |
|---|---|---|
| | ||
| August 22, 2024 | | /s/ Robert V. Baumgartner |
| | Robert V. Baumgartner | |
| | Chairman of the Board and Director | |
| | ||
| August 22, 2024 | | /s/ Julie Bushman |
| | Julie Bushman, Director | |
| | ||
| August 22, 2024 | | /s/ Rupert Vessey |
| | Dr. Rupert Vessey, Director | |
| | ||
| August 22, 2024 | | /s/ Joseph Keegan, Ph.D. |
| | Dr. Joseph Keegan, Director | |
| | ||
| August 22, 2024 | | /s/ John L. Higgins |
| | John L. Higgins, Director | |
| | ||
| August 22, 2024 | | /s/ Roeland Nusse, Ph.D. |
| | Dr. Roeland Nusse, Director | |
| | ||
| August 22, 2024 | | /s/ Alpna Seth, Ph.D. |
| | Dr. Alpna Seth, Director | |
| | ||
| August 22, 2024 | | /s/ Randolph C. Steer, Ph.D., M.D. |
| August 22, 2024 | | Dr. Randolph C. Steer, Director/s/ Judith Klimovsky, M.D. |
| | | Dr. Judith Klimovsky, Director |
| | ||
| August 22, 2024 | | /s/ Kim Kelderman |
| | Kim Kelderman, Director and Chief Executive Officer (principal executive officer) | |
| | ||
| August 22, 2024 | | /s/ James Hippel |
| | James Hippel, Chief Financial Officer | |
| | (principal financial officer and principal accounting officer) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.